CD4 Cell Counts and Toxoplasma Seroprevalence
Sir-We appreciate Dr. Glatt's interest [1] in our study of Toxoplasma seroprevalence in HIV-infected women in the United States [2] . We regret the omission of the study by Glatt et al. [3] from our references but failed to find the article in the Medline search performed during our literature review process. It is interesting to note that the 22.6% Toxoplasma seroprevalence rate reported in their cohort of 319 patients (which included 93 women) was just slightly greater than the range we cited in our study (3%-22%).
As stated in our study discussion, we were unable to explain the higher Toxoplasma seroprevalence rate among patients with CD4 cell counts of 200-500 cells/ mm 3 . It is important to note that, although there was a trend towards higher seroprevalence rates among patients with lower CD4 cell counts, this was statistically significant only for patients with CD4 cell counts of 200-500 cells/mm 3 (on univariate and multivariate analysis) and not for patients with CD4 cell counts of !200 cells/mm 3 . This association with CD4 cell count stratum could not be explained by country of birth or by age, because these variables were controlled for in the multivariate analysis. Consistent with the observations of Glatt et al. [3] , we found that, among HIV-infected women in the United States, country of birth (i.e., birth outside the United States) was the most potent predictor of Toxoplasma seropositivity. and Eric C. Seaberg
